Martin Petersen's Contact Details

Martin Petersen's Company Details

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp